Recommendations for inhaled corticosteroids must be exercised after great cautionAfter an evidence was found suggesting that some of the presently-used anti-inflammatory medications increase the risk of pneumonia by a full third, Lung disease experts at Johns Hopkins made a call for caution while recommendations are made by doctors while prescribing inhaled corticosteroids to people with COPD (chronic obstructive pulmonary disease).

COPD is believed to affect more than 11 million Americans on a yearly basis and most of this affected population belongs to the category of present or former smokers.

Pulmonologist M. Brad Drummond, M.D., M.H.S., who led the study, remarked that findings of this study are expected to provide a reminder to patients with severe lung disease to plan and take steps for reducing the risk of pneumonia, which doubles their risk of dying.